Cardiovascular diseases are the most common causes of mortality worldwide. They are
frequently the reasons for patient hospitalization, their incapability for work, and disability …

The direct toxicity of cancer treatment threatens patients and survivors with an increased risk
of cardiovascular disease or adverse functional changes with subsequent progression of …

Simple Summary The incidence and prevalence of cancer mainly affect the geriatric
population. In this segment of the population, streamlining cancer care and making it more …

Introduction The increasing survival of patients with breast cancer has prompted the
assessment of mortality due to all causes of death in these patients. We estimated the …

Background Anthracyclines and monoclonal antibodies against human epidermal growth
factor receptor-2 (HER2) are frequently used to treat breast cancer but they are associated …

Lung cancer is the third most common type of cancer in the UK, with nearly 50 000 new
cases diagnosed a year. Treatments for lung cancer have improved in recent years with the …

Purpose Cardiovascular disease is a competing mortality cause in hematological cancer
survivors due to toxic oncological treatment, accumulation of risk factors, and decline of …

Purpose of Review A critical evaluation of contemporary literature regarding the role of big
data, artificial intelligence, and digital technologies in precision cardio-oncology care and …

Background Trastuzumab is used, alone or in conjunction with standard chemotherapy, to
treat HER2-positive breast cancer (BC). Although it improves cancer outcomes, trastuzumab …

Purpose. The purpose of this study was to determine the feasibility and preliminary efficacy
of a cardiac rehabilitation (CR) intervention in the breast cancer population. Methods. This …